Cultivating the Future: Cell Culture Media Market Set to Grow at a CAGR of 7.2% with Rising Demand | DataHorizzon Research

The cell culture media market size was valued at USD 3.11 Billion in 2023 and is expected to reach a market size of USD 5.83 Billion by 2032 at a CAGR of 7.2%

Fort Collins, Colorado, April 12, 2024 (GLOBE NEWSWIRE) —

Advancements in regenerative medicine and stem cell research to propel the cell culture media market.

One of the key drivers of the cell culture media market is the emergence of regenerative medicine and stem cell research. This new cutting-edge field largely depends on the ability to culture and engineer kinds of stem cells, whether embryonic or adult. Specialized media formulations are required to uphold the pluripotent and proliferation of stem cells and direct their differentiation into many lineage-restricted cell types. As regenerative medicine and stem cell therapy research advances, the demand for tailored cell culture media solutions is anticipated to rise significantly.

The development of the biopharmaceutical sector is a prime stimulus behind the expansion of the cell culture media market. The increasing prevalence of biopharmaceuticals, including therapeutic proteins, monoclonal antibodies, and vaccines, has propelled the demand for effective and efficient cell culture systems. Chinese hamster ovary cells are required for biologics production; many innovative biopharmaceuticals have been developed. The above-mentioned factors have necessitated the use of specially formulated cell culture media. Additionally, the increasing prevalence of chronic diseases and rising focus on personalized medication have increased the popularity of innovative biopharmaceuticals.

Overall, the market of cell culture media is an attractive field of intensive development of novel chemically defined and serum-free media formulations. While conventional cell culture media frequently include components derived from animal presence, including fetal bovine serum, which results in variability and potential risk of contamination, the newly developed alternatives demonstrate better consistency, lower contamination risk, and improved compatibility with regulatory authorities’ requirements. With the broadening demand for improved performance of media formulations in all fields of application, manufacturers have the chance to invest in additional R&D to produce more innovative and efficient offerings.

Request Sample Report:

Segmentation Overview:

The cell culture media market has been segmented into product type, application, end-user, and region.

Serum-containing Media led the product segment in 2023.

  • Based on the market segmentation by product type, the largest sub-segment in 2023 was likely serum-containing media. This traditional media formulation, which contains animal-derived components like fetal bovine serum, has been widely used in cell culture applications for decades due to its ability to support cell growth and proliferation effectively. However, the demand for serum-containing media is expected to gradually decline as the biopharmaceutical industry shifts towards more advanced and regulatory-compliant media formulations.  

Rise in applications of cell culture media across the biopharmaceuticals segment. 

  • Based on the market segmentation by application, the largest sub-segment in 2023 was biopharmaceuticals. The biopharmaceutical industry has been a major driver for the cell culture media market, as the production of biologics such as therapeutic proteins, monoclonal antibodies, and vaccines heavily relies on efficient and reliable cell culture systems. The growing demand for biopharmaceuticals, driven by the increasing prevalence of chronic diseases and the need for advanced therapeutic interventions, has fueled the consumption of specialized cell culture media formulations.

Asia-Pacific to lead the regional growth 

  • The Asia-Pacific region is expected to be the fastest-growing market for cell culture media in the near future. According to a report by the World Health Organization, the incidence of chronic diseases is rising rapidly in the Asia-Pacific region, with an estimated 88 million new cases of cancer expected by 2030. The growing burden of chronic diseases, coupled with increasing investments in biotechnology research and the presence of a large patient population, is driving the demand for biopharmaceuticals and cell therapies, consequently boosting the growth of the cell culture media market in this region. 

Ask For Discount

Cell Culture Media Market Report Highlights:

  • The cell culture media market is anticipated to grow at a CAGR of 7.2%; the market size to reach USD 5.83 billion by 2032.
  • Rise of biopharmaceuticals, boom in stem-cell research and a shift towards animal-free media are anticipated to drive the market growth.
  • Compliance with the strict regulations issued by the U.S. and European governments related to cell culture media in biopharmaceutical manufacturing is expected to be challenging.
  • The largest regional market for cell culture media in 2023 was North America. According to a report by the U.S. Department of Health and Human Services, the United States accounted for over 60% of the global cell and gene therapy clinical trials as of January 2023.
  • Some prominent players in the cell culture media market report include Thermo Fisher Scientific, Merck (Sigma-Aldrich), Corning Incorporated, Lonza, FUJIFILM Irvine Scientific, Cytiva (formerly GE Healthcare Life Sciences), Sartorius, Biological Industries, PAN-Biotech, Zenbio, Boca Scientific, and MilliporeSigma. 

Cell Culture Media Market Segmentation:

By Product Type: Serum-containing Media, Serum-free Media, Protein-free Media, Chemically Defined Media

By Application: Cancer Research, Biopharmaceuticals, Regenerative Medicine & Tissue Engineering, Stem Cell Technologies, Others

By End-User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Centers

By Region: North America, Latin America, Europe, Asia Pacific, the Middle East and Africa.

Looking Exclusively For Region/Country Specific Report?

About DataHorizzon Research:

DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.



Ph: +1-970-672-0390


Follow Us: LinkedIn 


Recent Publications

Health Information Exchange Market

Artificial Intelligence in Diagnostics Market

Disposable and Reusable Mask Market

Artificial Intelligence in Genomics Market

MRI Market

CONTACT: Mail: Ph: +1-970-672-0390 Website: 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy